Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00482253
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
U66 | (20S)-19,20,22,23-TETRAHYDRO-19- OXO-5H,21H-18,20-ETHANO-12,14-ETHENO- 6,10-METHENOBENZ[D]IMIDAZO[4,3- L][1,6,9,13]OXATRIAZACYCLONOADECOSINE- 9-CARBONITRILE | B | 1LD7 | 0.71 | |
C12 | 2-(1-AMINO-2-HYDROXYPROPYL)-4-(4- HYDROXYBENZYL)-1-(2-OXOETHYL)-1H- IMIDAZOL-5-OLATE | A | 2FZU | 0.71 | |
MIM | [CYCLOHEXYLETHYL]-[[[[4-[2-METHYL- 1-IMIDAZOLYL-BUTYL]PHENYL]ACETYL]- SERYL]-LYSINYL]-AMINE | A | 2NMT | 0.73 | |
MIM | [CYCLOHEXYLETHYL]-[[[[4-[2-METHYL- 1-IMIDAZOLYL-BUTYL]PHENYL]ACETYL]- SERYL]-LYSINYL]-AMINE | A,B | 1IYK | 0.73 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHJ | 0.71 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHK | 0.71 | |
R86 | 2-{(2R)-4-[2-(1H-IMIDAZOL-1-YL)- 6-METHYLPYRIMIDIN-4-YL]-1-ISOBUTYRYLPIPERAZIN- 2-YL}-N-[2-(4-METHOXYPHENYL)ETHYL]ACETAMIDE | A | 2ORP | 0.74 | |
228 | N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]- 1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN- 4-YL]-D-PROLINAMIDE | A | 2ORO | 0.71 | |
GPB | N-[4-[2-(2-AMINO-4-METHYL-7H-PYRROLO[2,3- D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYL]GLUTAMIC ACID | A | 1E26 | 0.71 | |
FR2 | 1-((1R)-1-(HYDROXYMETHYL)-3-PHENYLPROPYL)- 1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1NDW | 0.75 | |
CSH | [2-(2-HYDROXY-1-METHYL-ETHYL)-4- (1H-IMIDAZOL-4-YLMETHYL)-5-OXO- IMIDAZOLIDIN-1-YL]-ACETIC ACID | A | 2EMN | 0.7 | |
CSH | [2-(2-HYDROXY-1-METHYL-ETHYL)-4- (1H-IMIDAZOL-4-YLMETHYL)-5-OXO- IMIDAZOLIDIN-1-YL]-ACETIC ACID | A | 1EMF | 0.7 | |
CSH | [2-(2-HYDROXY-1-METHYL-ETHYL)-4- (1H-IMIDAZOL-4-YLMETHYL)-5-OXO- IMIDAZOLIDIN-1-YL]-ACETIC ACID | A | 2EMD | 0.7 | |
CSH | [2-(2-HYDROXY-1-METHYL-ETHYL)-4- (1H-IMIDAZOL-4-YLMETHYL)-5-OXO- IMIDAZOLIDIN-1-YL]-ACETIC ACID | A | 2EMO | 0.7 | |
RC7 | {(2R)-4-(4-HYDROXYBENZYL)-2-[2- (1H-IMIDAZOL-4-YL)ETHYL]-5-OXO- 2,5-DIHYDRO-1H-IMIDAZOL-1-YL}ACETALDEHYDE | A,B,C,D | 2GW4 | 0.82 | |
GSZ | N-[(5R,6R,7R,8S)-6,7-DIHYDROXY- 5-(HYDROXYMETHYL)-2-(2-PHENYLETHYL)- 1,5,6,7,8,8A-HEXAHYDROIMIDAZO[1,2- A]PYRIDIN-8-YL]-2-METHYLPROPANAMIDE | A,B | 2J62 | 0.76 | |
T19 | PHENYLMETHYLENECARBOXY-(METHYLENEAMINO- FORMYL-DIPHENYLMETHYL)METHY-PRO- BOROVAL | H,I | 1AIX | 0.71 | |
SU9 | (3Z)-3-(1H-IMIDAZOL-5-YLMETHYLENE)- 5-METHOXY-1H-INDOL-2(3H)-ONE | A | 1PF8 | 0.71 | |
C60 | [[[3-(2-METHYL-PROPANE-2-SULFONYL)- 1-BENZENYL]-2-PROPYL]-CARBONYL- HISTIDYL]-AMINO-[CYCLOHEXYLMETHYL]- [2-HYDROXY-4-ISOPROPYL]-PENTAN- 5-OIC ACID BUTYLAMIDE | A | 1RNE | 0.74 | |
VGB | (5R,6R,7R,8S)-6,7-dihydroxy-5-(hydroxymethyl)- 2-(2-phenylethyl)-8-(propanoylamino)- 5,6,7,8-tetrahydro-1H-imidazo[1,2- a]pyridin-4-ium | A,B | 2WB5 | 0.76 | |
IM1 | B | 1BDQ | 0.8 | ||
IM1 | A,B | 1TCW | 0.8 | ||
IM1 | A | 1SBG | 0.8 | ||
IM1 | A,B | 1BDL | 0.8 | ||
IM1 | B | 1BDR | 0.8 | ||
IM1 | A | 1TCX | 0.8 | ||
FOL | FOLIC ACID | A | 1PJ6 | 0.7 | |
FOL | FOLIC ACID | A,B | 1RD7 | 0.7 | |
FOL | FOLIC ACID | A,B | 1DHF | 0.7 | |
FOL | FOLIC ACID | A,B,C,D,E | 1QZF | 0.7 | |
FOL | FOLIC ACID | A | 4CD2 | 0.7 | |
FOL | FOLIC ACID | A | 1RX7 | 0.7 | |
FOL | FOLIC ACID | A | 1RX2 | 0.7 | |
FOL | FOLIC ACID | A | 1RX8 | 0.7 | |
FOL | FOLIC ACID | A | 1RA2 | 0.7 | |
FOL | FOLIC ACID | A,B | 1RE7 | 0.7 | |
FOL | FOLIC ACID | A | 7DFR | 0.7 | |
FOL | FOLIC ACID | A | 1VIF | 0.7 | |
FOL | FOLIC ACID | A,B | 1RB2 | 0.7 | |
FOL | FOLIC ACID | A | 1CD2 | 0.7 | |
FOL | FOLIC ACID | A | 2CD2 | 0.7 | |
FOL | FOLIC ACID | A,B | 1DYI | 0.7 | |
FOL | FOLIC ACID | A | 1DRF | 0.7 | |
FOL | FOLIC ACID | A,B,C,D | 3BMC | 0.7 | |
FOL | FOLIC ACID | A,B | 2D0K | 0.7 | |
FOL | FOLIC ACID | A | 1RA8 | 0.7 | |
IH3 | 2-(2,2-DIPHENYL-ETHYL)-7-METHYL- 1,3-DIOXO-2,3,5,8-TETRAHYDRO-1H- [1,2,4] TRIAZOLO[1,2-A]PYRIDAZINE- 5-CARBOXYLIC ACID [4-(2-AMINO-3H- IMIDAZOL-4-YL)-CYCLOHEXYL]-AMIDE | 2,3 | 1C4Y | 0.71 | |
HBN | N-(2-NAPHTHYL)HISTIDINAMIDE | B | 1VEA | 0.74 | |
FR3 | 1-((1R)-1-(HYDROXYMETHYL)-3-(1- NAPHTHYL)PROPYL)-1H-IMIDAZOLE-4- CARBOXAMIDE | A | 1NDY | 0.71 | |
CX1 | N-[(benzyloxy)carbonyl]-L-histidyl- N-methyl-L-phenylalanyl-L-tyrosine | B | 3C72 | 0.88 | |
FR6 | 1-{(1R,2S)-2-HYDROXY-1-[2-(1-NAPHTHYL)ETHYL]PROPYL}- 1H-IMIDAZOLE-4-CARBOXAMIDE | A | 2E1W | 0.71 | |
PGI | (5R,6R,7S,8S)-5-(HYDROXYMETHYL)- 2-(2-PHENYLETHYL)-1,5,6,7,8,8A- HEXAHYDROIMIDAZO[1,2-A]PYRIDINE- 6,7,8-TRIOL | A,B | 2CET | 0.71 | |
PGI | (5R,6R,7S,8S)-5-(HYDROXYMETHYL)- 2-(2-PHENYLETHYL)-1,5,6,7,8,8A- HEXAHYDROIMIDAZO[1,2-A]PYRIDINE- 6,7,8-TRIOL | A,B | 2CER | 0.71 | |
GDV | (5R,6R,7R,8S)-8-(ACETYLAMINO)-6,7- DIHYDROXY-5-(HYDROXYMETHYL)-N-PHENYL- 1,5,6,7,8,8A-HEXAHYDROIMIDAZO[1,2- A]PYRIDINE-2-CARBOXAMIDE | A | 2J47 | 0.71 | |
IH4 | N-(R-CARBOXY-ETHYL)-ALPHA-(S)-(2- PHENYLETHYL) | A | 2BJU | 0.71 | |
REM | Nalpha-[(2S)-2-benzyl-3-(tert-butylsulfonyl)propanoyl]- N-[(1S,2R,3S)-1-(cyclohexylmethyl)- 3-cyclopropyl-2,3-dihydroxypropyl]- L-histidinamide | A,B | 3D91 | 0.79 | |
5AM | BENZYL {(1S)-5-AMINO-1-[(S)-HYDROXY(5- {[4-(4-PHENYLBUTANOYL)PIPERAZIN- 1-YL]METHYL}-1,2,4-OXADIAZOL-3- YL)METHYL]PENTYL}CARBAMATE | A,B,C,D | 2GDD | 0.71 | |
XX5 | (S,S)-2-{1-CARBOXY-2-[3-(3,5-DICHLORO- BENZYL)-3H-IMIDAZOL-4-YL]-ETHYLAMINO}- 4-METHYL-PENTANOIC ACID | A | 1R4L | 0.77 | |
INP | 4-[[N-[(PHENYLMETHOXY)CARBONYL]- /NL/N-LEUCYL]AMINO]-1[(2S)-2-[[[4- (PYRIDINYLMETHOXY)CARBONYL]AMINO]- 4-METHYLPENT/NYL]-3-PYRROLIDINONE/N | A | 1AU4 | 0.75 | |
4RB | 4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2- b]pyridazin-3-yl)benzoic acid | A | 3BQR | 0.74 | |
MT1 | N-(4-{[(2,4-DIAMINOPTERIDIN-1-IUM- 6-YL)METHYL](METHYL)AMINO}BENZOYL)- L-GLUTAMIC ACID | A,B | 2INQ | 0.72 | |
G14 | 2-phenyl-1H-imidazole-4-carboxylic acid | A,B | 3GRJ | 0.73 | |
ONM | 3'-O-(N-METHYLANTHRANILOYL)-GUANOSINE- 5'-TRIPHOSPHATE | A,C | 1TL7 | 0.71 | |
ONM | 3'-O-(N-METHYLANTHRANILOYL)-GUANOSINE- 5'-TRIPHOSPHATE | A,C | 1U0H | 0.71 | |
GRD | benzyl (S)-1-((2S,3S)-1-(3-(6-amino- 9H-purin-9-yl)propylamino)-2-hydroxy- 1-oxopentan-3-ylamino)-4-methyl- 1-oxopentan-2-ylcarbamate | A | 2R9C | 0.79 | |
IEY | 2-((1E)-2-(5-IMIDAZOLYL)ETHENYL)- 4-(P-HYDROXYBENZYLIDENE)-5-IMIDAZOLINONE | A,B,C,D | 2BTJ | 0.77 | |
IEY | 2-((1E)-2-(5-IMIDAZOLYL)ETHENYL)- 4-(P-HYDROXYBENZYLIDENE)-5-IMIDAZOLINONE | A,B,C,D | 2VVJ | 0.77 | |
RUN | 2-[(1R,3S,4S)-1-BENZYL-4-[N-(BENZYLOXYCARBONYL)- L-VALYL]AMINO-3-PHENYLPENTYL]-4(5)- (2-METHYLPROPIONYL)IMIDAZOLE | B | 1HPS | 0.85 |